Antibiotic resistance: Relationship to persistence of group A streptococci in the upper respiratory tract

Pediatrics

Volumn 97, Issue 6 II SUPPL., 1996, Pages 971-975

  Gerber, Michael A ^a  

^a Farmington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UPPER RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; LACTAMS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PYOGENES; SULFONAMIDES; TETRACYCLINE;

EID: 0030015052     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (59)

1. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268-274
2. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr. 1993;123:679-685
3. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-7
4. Veasy GL, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 1994;124:9-16
5. Finland M, Garner C, Wilcox C, et al. Susceptibility of beta-hemolytic streptococci to 65 antibacterial agents. Antimicrob Agents Chemother. 1976;9:11-19
6. Bourbeau P, Campos JM. Current antibiotic susceptibility of group A beta-hemolytic streptococci. J Infect Dis. 1982;145:916
7. Istre GR, Welch DF, Marks MI, et al. Susceptibility of group A beta-hemolytic streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother. 1981;20:244-246
8. Bass JW, Weisse ME, Plymyer MR, et al. Decline of erythromycin resistance of Group A beta-hemolytic streptococci in Japan. Arch Pediatr Adolesc Med. 1994;148:67-71
9. Coonan KM, Kaplan EL. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr Infect Dis J. 1994;13:630-635
10. Gutman L, Tomasz A. Penicillin-resistant and penicillin-tolerant mutants of group A streptococci. Antimicrob Agents Chemother. 1982;22: 128-136
11. Bryan LE, Godfrey AJ. Beta-lactam antibiotics: mode of action and bacterial resistance. In: Lorian V, ed. Antibiotics in Laboratory Medicine. 3rd ed. Baltimore: Williams and Wilkins; 1991:599-664
12. Rosendal K. Investigation of penicillin resistant streptococci belonging to group A. Acta Pathol Microbiol Scand. 1957;39:181-188
13. Austrian R. Confronting drug-resistant pneumococci. Ann Intern Med. 1994;121:807-809
14. Eagle H. Experimental approach to the problem of treatment failure with penicillin. 1. Group A streptococcal infection in mice. Am J Med. 1952;13:389-399
15. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23-28
16. Stevens DL, Van S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993;167: 1401-1405
17. Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985;107:681-684
18. Krasinski K, Hanna B, LaRussa P, et al. Penicillin tolerant group A streptococci. Diagn Microbiol Infect Dis. 1986;4:291-297
19. Allen JL, Sprunt K. Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B beta-hemolytic streptococci. J Pediatr. 1978;93:69-71
20. Grahn E, Holm SE, Roos K. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. Scand J Infect Dis. 1987;19:421-426
21. Smith TD, Huskins WC, Kim KS, et al. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr. 1987;110:777-782
22. Stjernquist-Desatnik A, Orrling A, Schalen C, et al. Penicillin tolerance in group A streptococci and treatment failure in streptococcal tonsillitis. Acta Otolaryngol. 1992;12(suppl 492):68-71
23. Lowbury EJL. Symposium on epidemiological risks of antibiotics. Hospital infections. Proc R Soc Med. 1958;51:807-810
24. Maruyama S, Yoshioka H, Fujita K, et al. Sensitivity of group A streptococci to antibiotics. Am J Dis Child. 1979;133:1143-1145
25. Miyamoto Y, Takizawa K, Matsushima A, et al. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Antimicrob Agents Chemother. 1978;13: 399-404
26. Nakae M, Murai T, Kaneko Y, et al. Drug resistance in Streptococcus pyogenes isolated in Japan (1974-1975). Antimicrob Agents Chemother. 1977;12:427-428
27. Fujii R. Consumption of antibiotics in Japan. Chemotherapy. 1977;25: 418-423
28. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of Group A streptococci in Japan. Pediatr Infect Dis. 1994;13: 1075-1078
29. Zackrisson G, Lind L, Roos K, et al. Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden. Scand J Infect Dis. 1988;20:419-420
30. Holmström L, Nyman B, Rosengren M, et al. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centers. Scand J Inject Dis. 1990;22:179-185
31. Phillips G, Parratt D, Orange GU, et al. Erythromycin-resistant Streptococcus pyogenes. J Antimicrob Chemother. 1990;25:723-724
32. Warren RE, Haines D, Walpole E, et al. Erythromycin-resistant Streptococcus pneumoniae. Lancet. 1988;2:1432-1433
33. Winstanley TG, Wilcox MH, Spencer RC. Combined resistance to erythromycin and tetracycline in streptococci. J Antimicrob Chemother. 1991; 28:154-156
34. Betriu C, Sanchez A, Gomez M, et al. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother. 1993;37:1717-1719
35. Rudensky B, Isaacson M, Beck A, et al. Increase in frequency of serious group A streptococcal infections. Isr J Med Sci. 1992;28:752-753
36. Järvinen H, Nissinen A, Huovinen P. Erythromycin resistance in group A streptococci. Lancet. 1989;1:1022-1023
37. Seppälä H, Nissinen A, Järvinen H, et al. Resistance to erythromycin in group A streptococci. N Engl J Med. 1992;326:292-297
38. Dixon JMS. Group A streptococcus resistant to erythromycin and lincomycin. Can Med Assoc J. 1968;99:1093-1094
39. Dixon JMS, Lipinski AE. Infection with beta-hemolytic streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin. J Infect Dis. 1974;130:351-356
40. Sanders E, Foster MT, Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med. 1968;278: 538-540
41. Eickhoff TC, Finland M. In vitro susceptibility of group A beta-hemolytic streptococci to 18 antibiotics. Am J Med Sci. 1965;249:261-268
42. Haddy RI, Gordon RC, Shamiyeh L, et al. Erythromycin resistance in group A beta-hemolytic streptococci. Pediatr Infect Dis. 1982;1:236-238
43. Arthur JD, Keiser JF, Brown SL, et al. Erythromycin-resistant group A beta-hemolytic streptococci: prevalence at four medical centers. Pediatr Infect Dis. 1984;3:489
44. Wittler RR, Yamada SM, Bass JW, et al. Penicillin tolerance and erythromycin resistance of group A beta-hemolytic streptococci in Hawaii and the Philippines. Am J Dis Child. 1990;144:587-589
45. Gentry JL, Burns WW. Antibiotic-resistant streptococci. Am J Dis Child. 1980;134:801
46. Brorson JE, Larsson P. The regression line for erythromycin is not valid for beta-hemolytic streptococci group A. Scand J Infect Dis. 1987;19: 243-246
47. Hooton TM. A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. Am J Med. 1991;91(suppl 3A): 23S-26S
48. Schrock CG. Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. J Fam Pract. 1992;35:622-626
49. O'Brien TF. Global surveillance of antibiotic resistance. N Engl J Med. 1992;326:339-340
50. Scott RJD, Naidoo J, Lightfoot NF, et al. A community outbreak of group A beta-hemolytic streptococci with transferable resistance to erythromycin. Epidemiol Infect. 1989;102:85-91
51. Horaud T, Le Bouguenec C, Pepper K. Molecular genetics of resistance to macrolides, lincosamides, and streptogramin B (MLS) in streptococci. J Antimicmb Chemother. 1985;16(suppl A):111-135
52. Lowbury EJL, Cason JS. Aureomycin and erythromycin therapy for Streptococcus pyogenes in burns. Br Med J. 1954;2:914-915
53. Mogabgab WJ, Felon W. An outbreak of pharyngitis due to tetracycline-resistant group A, Type 12 streptococci. Am J Dis Child. 1958; 96:696-698
54. Kuharic HA, Roberts CE Jr, Kirby WMM. Tetracycline resistance of group A beta-hemolytic streptococci. JAMA. 1960;174:1779-1782
55. Delameter ED, Jennings R, Wallace A. Preliminary report of an outbreak of streptococcal disease caused by a sulfadiazine-resistant group A hemolytic streptococcus. J Infect Dis. 1946;78:118-127
56. Hamburger M Jr, Mattman CH, Grosch DS, et al. Susceptibility to sulfadiazine of hemolytic streptococci recovered in army camps. Am J Med. 1946;1:23-27
57. Honikman CH, Massell BF, Goodell RA, et al. Treatment of group A streptococcal infections: comparison of sulfamethoxazole and buffered penicillin G. Am J Dis Child. 1969;117:451-457
58. Morris AJ, Chamovitz R, Catanzaro FJ, et al. Prevention of rheumatic fever by treatment of previous streptococcic infections: effect of sulfadiazine. JAMA. 1956;160:114-116
59. Kohn J, Evans AJ. Group A streptococci resistant to clindamycin. Br Med J. 1970;1:423